Underlying mechanism of the contractile dysfunction in atrophied ventricular myocytes from a murine model of hypothyroidism

[Display omitted] •Within 3 weeks, hypothyroidism induced cardiac atrophy and contractile dysfunction.•Blunted contractility was accompanied by slow SERCA due to reduced SERCA/PLB ratio.•Staggered and blunted calcium transients and diminished diastolic calcium leak.•Ventricular T-tubules, mitochondr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cell calcium (Edinburgh) 2018-06, Vol.72, p.26-38
Hauptverfasser: Montalvo, Dolores, Pérez-Treviño, Perla, Madrazo-Aguirre, Katheryne, González-Mondellini, Fabio A., Miranda-Roblero, Hipólito O., Ramonfaur-Gracia, Diego, Jacobo-Antonio, Mariana, Mayorga-Luna, Maritza, Gómez-Víquez, Norma. L., García, Noemí, Altamirano, Julio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 38
container_issue
container_start_page 26
container_title Cell calcium (Edinburgh)
container_volume 72
creator Montalvo, Dolores
Pérez-Treviño, Perla
Madrazo-Aguirre, Katheryne
González-Mondellini, Fabio A.
Miranda-Roblero, Hipólito O.
Ramonfaur-Gracia, Diego
Jacobo-Antonio, Mariana
Mayorga-Luna, Maritza
Gómez-Víquez, Norma. L.
García, Noemí
Altamirano, Julio
description [Display omitted] •Within 3 weeks, hypothyroidism induced cardiac atrophy and contractile dysfunction.•Blunted contractility was accompanied by slow SERCA due to reduced SERCA/PLB ratio.•Staggered and blunted calcium transients and diminished diastolic calcium leak.•Ventricular T-tubules, mitochondrial density and ATP availability were unchanged.•Diminished calcium-dependent RyR2 sensitivity desynchronizes systolic SR release. Hypothyroidism (Hypo) is a risk factor for cardiovascular diseases, including heart failure. Hypo rapidly induces Ca2+ mishandling and contractile dysfunction (CD), as well as atrophy and ventricular myocytes (VM) remodeling. Hypo decreases SERCA-to-phospholamban ratio (SERCA/PLB), and thereby contributes to CD. Nevertheless, detailed spatial and temporal Ca2+ cycling characterization in VM is missing, and contribution of other structural and functional changes to the mechanism underlying Ca2+ mishandling and CD, as transverse tubules (T-T) remodeling, mitochondrial density (Dmit) and energy availability, is unclear. Therefore, in a rat model of Hypo, we aimed to characterize systolic and diastolic Ca2+ signaling, T-T remodeling, Dmit, citrate synthase (CS) activity and high-energy phosphate metabolites (ATP and phosphocreatine). We confirmed a decrease in SERCA/PLB (59%), which slowed SERCA activity (48%), reduced SR Ca2+ (19%) and blunted Ca2+ transient amplitude (41%). Moreover, assessing the rate of SR Ca2+ release (dRel/dt), we found that early and maximum dRel/dt decreased, and this correlated with staggered Ca2+ transients. However, dRel/dt persisted during Ca2+ transient relaxation due to abundant late Ca2+ sparks. Isoproterenol significantly up-regulated systolic Ca2+ cycling. T-T were unchanged, hence, cannot explain staggered Ca2+ transients and altered dRel/dt. Therefore, we suggest that these might be caused by RyR2 clusters desynchronization, due to diminished Ca2+-dependent sensitivity of RyR2, which also caused a decrease in diastolic SR Ca2+ leak. Furthermore, Dmit was unchanged and CS activity slightly decreased (14%), however, the ratio phosphocreatine/ATP did not change, therefore, energy deficiency cannot account for Ca2+ and contractility dysregulation. We conclude that decreased SR Ca2+, due to slower SERCA, disrupts systolic RyR2 synchronization, and this underlies CD.
doi_str_mv 10.1016/j.ceca.2018.01.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2038263887</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0143416017301938</els_id><sourcerecordid>2038263887</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-6cbd27dc01df1957b64bce4dd35a6f7c3127c913b886847c6acf34862e76ecd13</originalsourceid><addsrcrecordid>eNp9kMFu1DAQhi0EotvCC3BAPnJJ8MSJnUhcUFWgUiUu9Gw54wnxKrEXO6kU8fJktYUjp5nD9_-j-Rh7B6IEAerjsURCW1YC2lJAKUTzgh2gkVUBXQcv2UFALYsalLhi1zkfhRCd1PCaXVWdrluQcGC_H4OjNG0-_OQz4WiDzzOPA19G4hjDkiwufiLutjysYd9j4D5wu6R4Gj05_kQ75HGdbOLzFnFbKPMhxZlbPq_JB-JzdDSdS8ftFJdxS9G7_cwb9mqwU6a3z_OGPX65-3H7rXj4_vX-9vNDgbJRS6Gwd5V2KMAN0DW6V3WPVDsnG6sGjRIqjR3Ivm1VW2tUFgdZt6oirQgdyBv24dJ7SvHXSnkxs89I02QDxTWbSsi2UrJt9Y5WFxRTzDnRYE7JzzZtBoQ5SzdHc5ZuztKNALNL30Pvn_vXfib3L_LX8g58ugC0f_nkKZmMngKS84lwMS76__X_AUFhlls</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2038263887</pqid></control><display><type>article</type><title>Underlying mechanism of the contractile dysfunction in atrophied ventricular myocytes from a murine model of hypothyroidism</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Montalvo, Dolores ; Pérez-Treviño, Perla ; Madrazo-Aguirre, Katheryne ; González-Mondellini, Fabio A. ; Miranda-Roblero, Hipólito O. ; Ramonfaur-Gracia, Diego ; Jacobo-Antonio, Mariana ; Mayorga-Luna, Maritza ; Gómez-Víquez, Norma. L. ; García, Noemí ; Altamirano, Julio</creator><creatorcontrib>Montalvo, Dolores ; Pérez-Treviño, Perla ; Madrazo-Aguirre, Katheryne ; González-Mondellini, Fabio A. ; Miranda-Roblero, Hipólito O. ; Ramonfaur-Gracia, Diego ; Jacobo-Antonio, Mariana ; Mayorga-Luna, Maritza ; Gómez-Víquez, Norma. L. ; García, Noemí ; Altamirano, Julio</creatorcontrib><description>[Display omitted] •Within 3 weeks, hypothyroidism induced cardiac atrophy and contractile dysfunction.•Blunted contractility was accompanied by slow SERCA due to reduced SERCA/PLB ratio.•Staggered and blunted calcium transients and diminished diastolic calcium leak.•Ventricular T-tubules, mitochondrial density and ATP availability were unchanged.•Diminished calcium-dependent RyR2 sensitivity desynchronizes systolic SR release. Hypothyroidism (Hypo) is a risk factor for cardiovascular diseases, including heart failure. Hypo rapidly induces Ca2+ mishandling and contractile dysfunction (CD), as well as atrophy and ventricular myocytes (VM) remodeling. Hypo decreases SERCA-to-phospholamban ratio (SERCA/PLB), and thereby contributes to CD. Nevertheless, detailed spatial and temporal Ca2+ cycling characterization in VM is missing, and contribution of other structural and functional changes to the mechanism underlying Ca2+ mishandling and CD, as transverse tubules (T-T) remodeling, mitochondrial density (Dmit) and energy availability, is unclear. Therefore, in a rat model of Hypo, we aimed to characterize systolic and diastolic Ca2+ signaling, T-T remodeling, Dmit, citrate synthase (CS) activity and high-energy phosphate metabolites (ATP and phosphocreatine). We confirmed a decrease in SERCA/PLB (59%), which slowed SERCA activity (48%), reduced SR Ca2+ (19%) and blunted Ca2+ transient amplitude (41%). Moreover, assessing the rate of SR Ca2+ release (dRel/dt), we found that early and maximum dRel/dt decreased, and this correlated with staggered Ca2+ transients. However, dRel/dt persisted during Ca2+ transient relaxation due to abundant late Ca2+ sparks. Isoproterenol significantly up-regulated systolic Ca2+ cycling. T-T were unchanged, hence, cannot explain staggered Ca2+ transients and altered dRel/dt. Therefore, we suggest that these might be caused by RyR2 clusters desynchronization, due to diminished Ca2+-dependent sensitivity of RyR2, which also caused a decrease in diastolic SR Ca2+ leak. Furthermore, Dmit was unchanged and CS activity slightly decreased (14%), however, the ratio phosphocreatine/ATP did not change, therefore, energy deficiency cannot account for Ca2+ and contractility dysregulation. We conclude that decreased SR Ca2+, due to slower SERCA, disrupts systolic RyR2 synchronization, and this underlies CD.</description><identifier>ISSN: 0143-4160</identifier><identifier>EISSN: 1532-1991</identifier><identifier>DOI: 10.1016/j.ceca.2018.01.005</identifier><identifier>PMID: 29748131</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Atrophy ; Calcium - metabolism ; Calcium Signaling - drug effects ; Cardiac atrophy ; Citrate (si)-Synthase - metabolism ; Disease Models, Animal ; Heart Ventricles - drug effects ; Heart Ventricles - pathology ; Hypothyroidism - blood ; Hypothyroidism - physiopathology ; Male ; Mitochondria - drug effects ; Mitochondria - metabolism ; Myocardial Contraction - drug effects ; Myocardial Contraction - physiology ; Myocardium - metabolism ; Myocardium - pathology ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Myocytes, Cardiac - pathology ; Phospholamban ; Rats, Wistar ; Ryanodine receptors type 2 ; Sarcoplasmic Reticulum - drug effects ; Sarcoplasmic Reticulum - metabolism ; Sarcoplasmic Reticulum Calcium-Transporting ATPases - metabolism ; SERCA ; Systole - drug effects ; Thapsigargin - pharmacology ; Thyroid Hormones - blood ; Time Factors ; Transverse tubules</subject><ispartof>Cell calcium (Edinburgh), 2018-06, Vol.72, p.26-38</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright © 2018 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-6cbd27dc01df1957b64bce4dd35a6f7c3127c913b886847c6acf34862e76ecd13</citedby><cites>FETCH-LOGICAL-c356t-6cbd27dc01df1957b64bce4dd35a6f7c3127c913b886847c6acf34862e76ecd13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ceca.2018.01.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29748131$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montalvo, Dolores</creatorcontrib><creatorcontrib>Pérez-Treviño, Perla</creatorcontrib><creatorcontrib>Madrazo-Aguirre, Katheryne</creatorcontrib><creatorcontrib>González-Mondellini, Fabio A.</creatorcontrib><creatorcontrib>Miranda-Roblero, Hipólito O.</creatorcontrib><creatorcontrib>Ramonfaur-Gracia, Diego</creatorcontrib><creatorcontrib>Jacobo-Antonio, Mariana</creatorcontrib><creatorcontrib>Mayorga-Luna, Maritza</creatorcontrib><creatorcontrib>Gómez-Víquez, Norma. L.</creatorcontrib><creatorcontrib>García, Noemí</creatorcontrib><creatorcontrib>Altamirano, Julio</creatorcontrib><title>Underlying mechanism of the contractile dysfunction in atrophied ventricular myocytes from a murine model of hypothyroidism</title><title>Cell calcium (Edinburgh)</title><addtitle>Cell Calcium</addtitle><description>[Display omitted] •Within 3 weeks, hypothyroidism induced cardiac atrophy and contractile dysfunction.•Blunted contractility was accompanied by slow SERCA due to reduced SERCA/PLB ratio.•Staggered and blunted calcium transients and diminished diastolic calcium leak.•Ventricular T-tubules, mitochondrial density and ATP availability were unchanged.•Diminished calcium-dependent RyR2 sensitivity desynchronizes systolic SR release. Hypothyroidism (Hypo) is a risk factor for cardiovascular diseases, including heart failure. Hypo rapidly induces Ca2+ mishandling and contractile dysfunction (CD), as well as atrophy and ventricular myocytes (VM) remodeling. Hypo decreases SERCA-to-phospholamban ratio (SERCA/PLB), and thereby contributes to CD. Nevertheless, detailed spatial and temporal Ca2+ cycling characterization in VM is missing, and contribution of other structural and functional changes to the mechanism underlying Ca2+ mishandling and CD, as transverse tubules (T-T) remodeling, mitochondrial density (Dmit) and energy availability, is unclear. Therefore, in a rat model of Hypo, we aimed to characterize systolic and diastolic Ca2+ signaling, T-T remodeling, Dmit, citrate synthase (CS) activity and high-energy phosphate metabolites (ATP and phosphocreatine). We confirmed a decrease in SERCA/PLB (59%), which slowed SERCA activity (48%), reduced SR Ca2+ (19%) and blunted Ca2+ transient amplitude (41%). Moreover, assessing the rate of SR Ca2+ release (dRel/dt), we found that early and maximum dRel/dt decreased, and this correlated with staggered Ca2+ transients. However, dRel/dt persisted during Ca2+ transient relaxation due to abundant late Ca2+ sparks. Isoproterenol significantly up-regulated systolic Ca2+ cycling. T-T were unchanged, hence, cannot explain staggered Ca2+ transients and altered dRel/dt. Therefore, we suggest that these might be caused by RyR2 clusters desynchronization, due to diminished Ca2+-dependent sensitivity of RyR2, which also caused a decrease in diastolic SR Ca2+ leak. Furthermore, Dmit was unchanged and CS activity slightly decreased (14%), however, the ratio phosphocreatine/ATP did not change, therefore, energy deficiency cannot account for Ca2+ and contractility dysregulation. We conclude that decreased SR Ca2+, due to slower SERCA, disrupts systolic RyR2 synchronization, and this underlies CD.</description><subject>Animals</subject><subject>Atrophy</subject><subject>Calcium - metabolism</subject><subject>Calcium Signaling - drug effects</subject><subject>Cardiac atrophy</subject><subject>Citrate (si)-Synthase - metabolism</subject><subject>Disease Models, Animal</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - pathology</subject><subject>Hypothyroidism - blood</subject><subject>Hypothyroidism - physiopathology</subject><subject>Male</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardial Contraction - physiology</subject><subject>Myocardium - metabolism</subject><subject>Myocardium - pathology</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Myocytes, Cardiac - pathology</subject><subject>Phospholamban</subject><subject>Rats, Wistar</subject><subject>Ryanodine receptors type 2</subject><subject>Sarcoplasmic Reticulum - drug effects</subject><subject>Sarcoplasmic Reticulum - metabolism</subject><subject>Sarcoplasmic Reticulum Calcium-Transporting ATPases - metabolism</subject><subject>SERCA</subject><subject>Systole - drug effects</subject><subject>Thapsigargin - pharmacology</subject><subject>Thyroid Hormones - blood</subject><subject>Time Factors</subject><subject>Transverse tubules</subject><issn>0143-4160</issn><issn>1532-1991</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFu1DAQhi0EotvCC3BAPnJJ8MSJnUhcUFWgUiUu9Gw54wnxKrEXO6kU8fJktYUjp5nD9_-j-Rh7B6IEAerjsURCW1YC2lJAKUTzgh2gkVUBXQcv2UFALYsalLhi1zkfhRCd1PCaXVWdrluQcGC_H4OjNG0-_OQz4WiDzzOPA19G4hjDkiwufiLutjysYd9j4D5wu6R4Gj05_kQ75HGdbOLzFnFbKPMhxZlbPq_JB-JzdDSdS8ftFJdxS9G7_cwb9mqwU6a3z_OGPX65-3H7rXj4_vX-9vNDgbJRS6Gwd5V2KMAN0DW6V3WPVDsnG6sGjRIqjR3Ivm1VW2tUFgdZt6oirQgdyBv24dJ7SvHXSnkxs89I02QDxTWbSsi2UrJt9Y5WFxRTzDnRYE7JzzZtBoQ5SzdHc5ZuztKNALNL30Pvn_vXfib3L_LX8g58ugC0f_nkKZmMngKS84lwMS76__X_AUFhlls</recordid><startdate>201806</startdate><enddate>201806</enddate><creator>Montalvo, Dolores</creator><creator>Pérez-Treviño, Perla</creator><creator>Madrazo-Aguirre, Katheryne</creator><creator>González-Mondellini, Fabio A.</creator><creator>Miranda-Roblero, Hipólito O.</creator><creator>Ramonfaur-Gracia, Diego</creator><creator>Jacobo-Antonio, Mariana</creator><creator>Mayorga-Luna, Maritza</creator><creator>Gómez-Víquez, Norma. L.</creator><creator>García, Noemí</creator><creator>Altamirano, Julio</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201806</creationdate><title>Underlying mechanism of the contractile dysfunction in atrophied ventricular myocytes from a murine model of hypothyroidism</title><author>Montalvo, Dolores ; Pérez-Treviño, Perla ; Madrazo-Aguirre, Katheryne ; González-Mondellini, Fabio A. ; Miranda-Roblero, Hipólito O. ; Ramonfaur-Gracia, Diego ; Jacobo-Antonio, Mariana ; Mayorga-Luna, Maritza ; Gómez-Víquez, Norma. L. ; García, Noemí ; Altamirano, Julio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-6cbd27dc01df1957b64bce4dd35a6f7c3127c913b886847c6acf34862e76ecd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Atrophy</topic><topic>Calcium - metabolism</topic><topic>Calcium Signaling - drug effects</topic><topic>Cardiac atrophy</topic><topic>Citrate (si)-Synthase - metabolism</topic><topic>Disease Models, Animal</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - pathology</topic><topic>Hypothyroidism - blood</topic><topic>Hypothyroidism - physiopathology</topic><topic>Male</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardial Contraction - physiology</topic><topic>Myocardium - metabolism</topic><topic>Myocardium - pathology</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Myocytes, Cardiac - pathology</topic><topic>Phospholamban</topic><topic>Rats, Wistar</topic><topic>Ryanodine receptors type 2</topic><topic>Sarcoplasmic Reticulum - drug effects</topic><topic>Sarcoplasmic Reticulum - metabolism</topic><topic>Sarcoplasmic Reticulum Calcium-Transporting ATPases - metabolism</topic><topic>SERCA</topic><topic>Systole - drug effects</topic><topic>Thapsigargin - pharmacology</topic><topic>Thyroid Hormones - blood</topic><topic>Time Factors</topic><topic>Transverse tubules</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montalvo, Dolores</creatorcontrib><creatorcontrib>Pérez-Treviño, Perla</creatorcontrib><creatorcontrib>Madrazo-Aguirre, Katheryne</creatorcontrib><creatorcontrib>González-Mondellini, Fabio A.</creatorcontrib><creatorcontrib>Miranda-Roblero, Hipólito O.</creatorcontrib><creatorcontrib>Ramonfaur-Gracia, Diego</creatorcontrib><creatorcontrib>Jacobo-Antonio, Mariana</creatorcontrib><creatorcontrib>Mayorga-Luna, Maritza</creatorcontrib><creatorcontrib>Gómez-Víquez, Norma. L.</creatorcontrib><creatorcontrib>García, Noemí</creatorcontrib><creatorcontrib>Altamirano, Julio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cell calcium (Edinburgh)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montalvo, Dolores</au><au>Pérez-Treviño, Perla</au><au>Madrazo-Aguirre, Katheryne</au><au>González-Mondellini, Fabio A.</au><au>Miranda-Roblero, Hipólito O.</au><au>Ramonfaur-Gracia, Diego</au><au>Jacobo-Antonio, Mariana</au><au>Mayorga-Luna, Maritza</au><au>Gómez-Víquez, Norma. L.</au><au>García, Noemí</au><au>Altamirano, Julio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Underlying mechanism of the contractile dysfunction in atrophied ventricular myocytes from a murine model of hypothyroidism</atitle><jtitle>Cell calcium (Edinburgh)</jtitle><addtitle>Cell Calcium</addtitle><date>2018-06</date><risdate>2018</risdate><volume>72</volume><spage>26</spage><epage>38</epage><pages>26-38</pages><issn>0143-4160</issn><eissn>1532-1991</eissn><abstract>[Display omitted] •Within 3 weeks, hypothyroidism induced cardiac atrophy and contractile dysfunction.•Blunted contractility was accompanied by slow SERCA due to reduced SERCA/PLB ratio.•Staggered and blunted calcium transients and diminished diastolic calcium leak.•Ventricular T-tubules, mitochondrial density and ATP availability were unchanged.•Diminished calcium-dependent RyR2 sensitivity desynchronizes systolic SR release. Hypothyroidism (Hypo) is a risk factor for cardiovascular diseases, including heart failure. Hypo rapidly induces Ca2+ mishandling and contractile dysfunction (CD), as well as atrophy and ventricular myocytes (VM) remodeling. Hypo decreases SERCA-to-phospholamban ratio (SERCA/PLB), and thereby contributes to CD. Nevertheless, detailed spatial and temporal Ca2+ cycling characterization in VM is missing, and contribution of other structural and functional changes to the mechanism underlying Ca2+ mishandling and CD, as transverse tubules (T-T) remodeling, mitochondrial density (Dmit) and energy availability, is unclear. Therefore, in a rat model of Hypo, we aimed to characterize systolic and diastolic Ca2+ signaling, T-T remodeling, Dmit, citrate synthase (CS) activity and high-energy phosphate metabolites (ATP and phosphocreatine). We confirmed a decrease in SERCA/PLB (59%), which slowed SERCA activity (48%), reduced SR Ca2+ (19%) and blunted Ca2+ transient amplitude (41%). Moreover, assessing the rate of SR Ca2+ release (dRel/dt), we found that early and maximum dRel/dt decreased, and this correlated with staggered Ca2+ transients. However, dRel/dt persisted during Ca2+ transient relaxation due to abundant late Ca2+ sparks. Isoproterenol significantly up-regulated systolic Ca2+ cycling. T-T were unchanged, hence, cannot explain staggered Ca2+ transients and altered dRel/dt. Therefore, we suggest that these might be caused by RyR2 clusters desynchronization, due to diminished Ca2+-dependent sensitivity of RyR2, which also caused a decrease in diastolic SR Ca2+ leak. Furthermore, Dmit was unchanged and CS activity slightly decreased (14%), however, the ratio phosphocreatine/ATP did not change, therefore, energy deficiency cannot account for Ca2+ and contractility dysregulation. We conclude that decreased SR Ca2+, due to slower SERCA, disrupts systolic RyR2 synchronization, and this underlies CD.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>29748131</pmid><doi>10.1016/j.ceca.2018.01.005</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0143-4160
ispartof Cell calcium (Edinburgh), 2018-06, Vol.72, p.26-38
issn 0143-4160
1532-1991
language eng
recordid cdi_proquest_miscellaneous_2038263887
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Atrophy
Calcium - metabolism
Calcium Signaling - drug effects
Cardiac atrophy
Citrate (si)-Synthase - metabolism
Disease Models, Animal
Heart Ventricles - drug effects
Heart Ventricles - pathology
Hypothyroidism - blood
Hypothyroidism - physiopathology
Male
Mitochondria - drug effects
Mitochondria - metabolism
Myocardial Contraction - drug effects
Myocardial Contraction - physiology
Myocardium - metabolism
Myocardium - pathology
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - metabolism
Myocytes, Cardiac - pathology
Phospholamban
Rats, Wistar
Ryanodine receptors type 2
Sarcoplasmic Reticulum - drug effects
Sarcoplasmic Reticulum - metabolism
Sarcoplasmic Reticulum Calcium-Transporting ATPases - metabolism
SERCA
Systole - drug effects
Thapsigargin - pharmacology
Thyroid Hormones - blood
Time Factors
Transverse tubules
title Underlying mechanism of the contractile dysfunction in atrophied ventricular myocytes from a murine model of hypothyroidism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T21%3A34%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Underlying%20mechanism%20of%20the%20contractile%20dysfunction%20in%20atrophied%20ventricular%20myocytes%20from%20a%20murine%20model%20of%20hypothyroidism&rft.jtitle=Cell%20calcium%20(Edinburgh)&rft.au=Montalvo,%20Dolores&rft.date=2018-06&rft.volume=72&rft.spage=26&rft.epage=38&rft.pages=26-38&rft.issn=0143-4160&rft.eissn=1532-1991&rft_id=info:doi/10.1016/j.ceca.2018.01.005&rft_dat=%3Cproquest_cross%3E2038263887%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2038263887&rft_id=info:pmid/29748131&rft_els_id=S0143416017301938&rfr_iscdi=true